课题基金 / 基金详情

项目摘要

项目成果

YOANNIS IMBERT-FERNANDEZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dry eye disease is due to tear deficiency or excessive tear evaporation and results in inflammation and damage to the ocular surface. Mucins are highly O-glycosylated proteins that lubricate and protect the ocular surface. Recent findings indicate that the mucin MUC1 has anti-inflammatory properties and also can interact with estrogen receptor-alpha thereby modulating gene transcription. Androgens are key to maintaining homeostasis of the ocular surface. A potential interaction between MUC1 and androgen receptor (AR) could confer additional protection: My long term goal is to elucidate the molecular mechanisms involved in the pathogenesis of dry eye. My hypothesis is that MUC1 and androgen receptor (AR) are key factors that can act together to protect the ocular surface. The hypothesis will be tested by three specific aims: Aim 1- Determine the interaction between MUC1 and AR in human ocular surface epithelial cell lines; Aim 2- Elucidate the anti-inflammatory role of MUC1 and AR in those cells; and Aim 3- We have found that persons expressing the MUC1/A splice variant rather than MUC1/B are less susceptible to dry eye. We will determine if MUC1/A and MUC1/B splice variants differ in their signal transduction capabilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10650304
  • 项目类别:
  • 资助金额:
    $34.97万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10052862
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10430005
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors
  • 批准号:
    10213670
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2020
  • 负责人:
    YOANNIS IMBERT-FERNANDEZ
  • 依托单位:
海外基金